Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
1993-10-15
pubmed:abstractText
In rheumatoid arthritis (RA), the high diagnostic value of serum antibodies to the stratum corneum of rat esophagus epithelium has been widely reported. These so-called "antikeratin antibodies," detected by indirect immunofluorescence, were found to be autoantibodies since they also labeled human epidermis. Despite their name, the actual target of these autoantibodies was not known. In this study, a 40-kD protein (designated as 40K), extracted from human epidermis and specifically immunodetected by 75% of RA sera, was purified and identified as a neutral/acidic isoform of basic filaggrin, a cytokeratin filament-aggregating protein, by peptide mapping studies and by the following evidences: (a) mAbs specific for filaggrin reacted with the 40K protein; (b) the autoantibodies, affinity-purified from RA sera on the 40K protein, immunodetected purified filaggrin; (c) the reactivity of RA sera to the 40K protein was abolished after immunoadsorption with purified filaggrin; (d) the 40K protein and filaggrin had similar amino acid compositions. Furthermore, autoantibodies against the 40K protein and the so-called "antikeratin antibodies" were shown, by immunoadsorption experiments, to be largely the same. The identification of filaggrin as a RA-specific autoantigen could contribute to the understanding of the pathogenesis of this disease and, ultimately, to the development of methods for preventing the autoimmune response.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-111762, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1377463, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1379430, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-14178016, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1522214, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1716899, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1718228, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1722966, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1909642, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1951415, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-1996354, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2177109, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2188668, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2248957, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2261702, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2271017, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2366003, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2432133, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2434577, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2441454, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2448638, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2478084, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2531598, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2580092, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2646863, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2655929, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-2740331, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-320200, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-3358796, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-384931, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6166255, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6170061, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6185144, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6187370, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6188470, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6195345, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6205812, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6210364, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-6898623, http://linkedlifedata.com/resource/pubmed/commentcorrection/7690781-732879
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9738
pubmed:author
pubmed:issnType
Print
pubmed:volume
92
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1387-93
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
The cytokeratin filament-aggregating protein filaggrin is the target of the so-called "antikeratin antibodies," autoantibodies specific for rheumatoid arthritis.
pubmed:affiliation
Department of Biology and Pathology of the Cell, Toulouse-Purpan School of Medicine, University of Toulouse III, France.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't